Literature DB >> 35719445

Author Response to the Manuscript "Inflammation and Hemorrhagic Stroke Outcomes: Other Players in the Nexus".

Sethu Babu1, Mathew Pulicken2, Arun K Thazhathuveedu3.   

Abstract

How to cite this article: Babu S, Pulicken M, Thazhathuveedu AK. Author Response to the Manuscript "Inflammation and Hemorrhagic Stroke Outcomes: Other Players in the Nexus". Indian J Crit Care Med 2022;26(5):652.
Copyright © 2022; The Author(s).

Entities:  

Keywords:  Intracerebral hemorrhage; Neutrophil/Lymphocyte ratio; Serum albumin; Systemic inflammatory response syndrome

Year:  2022        PMID: 35719445      PMCID: PMC9160633          DOI: 10.5005/jp-journals-10071-24207

Source DB:  PubMed          Journal:  Indian J Crit Care Med        ISSN: 0972-5229


Author Response/Reply Thank you for your words of appreciation and for bringing up this interesting discussion which is relevant to our research. As you have mentioned, serum albumin has emerged as an additional prognostic biomarker in patients with acute stroke, although the evidence with respect to hemorrhagic stroke is scarce. Preliminary studies by Limaye et al.[1] and Kapoor et al.[2] have thrown important light in this regard, although the relationship of admission time serum albumin and the intensity of acute inflammatory response remain unclear. In this context, the results of a multicenter, multinational study—the MNEMONICH investigators—are worth discussing.[3] The aim of this study was to determine the association of admission serum albumin and systemic inflammatory response syndrome (SIRS) with outcomes in patients with intracerebral hemorrhage (ICH). They observed that in patients with ICH, hypoalbuminemia on admission is strongly associated with the presence and severity of SIRS. It was concluded that SIRS, but not hypoalbuminemia per se, predicts poor outcomes at discharge. This finding supports the hypothesis that serum albumin represents a biomarker of acute inflammatory response and the severity of hypoalbuminemia is proportional to the degree of inflammation in patients with ICH. We agree with your opinion that incorporating serum albumin with existing biomarkers like neutrophil–lymphocyte ratio (NLR) can provide us with a more accurate composite index for early identification of ICH patients at risk of poor outcomes. This will help us to develop future therapeutic strategies aimed at modulating this exaggerated inflammatory response occurring in a subset of hemorrhagic stroke patients. We shall look forward to further studies and evidence in this regard.

Orcid

Sethu Babu https://orcid.org/0000-0001-9259-5694 Mathew Pulicken https://orcid.org/0000-0001-9436-1031 Arun K Thazhathuveedu https://orcid.org/0000-0002-4701-9281
  3 in total

1.  Hypoalbuminemia, systemic inflammatory response syndrome, and functional outcome in intracerebral hemorrhage.

Authors:  Mario Di Napoli; Réza Behrouz; Christopher H Topel; Vivek Misra; Fulvio Pomero; Alessia Giraudo; Paolo Pennati; Luca Masotti; Floris H B M Schreuder; Julie Staals; Catharina J M Klijn; Craig J Smith; Adrian R Parry-Jones; Mark A Slevin; Brian Silver; Joshua Z Willey; Mahmoud R Azarpazhooh; Jaime Masjuán Vallejo; Hipólito Nzwalo; Aurel Popa-Wagner; Daniel A Godoy
Journal:  J Crit Care       Date:  2017-06-01       Impact factor: 3.425

2.  Role of admission serum albumin levels in patients with intracerebral hemorrhage.

Authors:  Kaustubh Limaye; Ju Dong Yang; Archana Hinduja
Journal:  Acta Neurol Belg       Date:  2015-07-02       Impact factor: 2.396

3.  Serum albumin level in spontaneous subarachnoid haemorrhage: More than a mere nutritional marker!

Authors:  Ankur Kapoor; Sivashanmugam Dhandapani; Sachin Gaudihalli; Manju Dhandapani; Harminder Singh; Kanchan K Mukherjee
Journal:  Br J Neurosurg       Date:  2017-06-29       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.